0000899243-22-009050.txt : 20220303
0000899243-22-009050.hdr.sgml : 20220303
20220303160539
ACCESSION NUMBER: 0000899243-22-009050
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220301
FILED AS OF DATE: 20220303
DATE AS OF CHANGE: 20220303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Thackaberry Evan
CENTRAL INDEX KEY: 0001889253
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41200
FILM NUMBER: 22708625
MAIL ADDRESS:
STREET 1: VIGIL NEUROSCIENCE, INC.
STREET 2: 300 TECHNOLOGY SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vigil Neuroscience, Inc.
CENTRAL INDEX KEY: 0001827087
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 TECHNOLOGY SQUARE
STREET 2: 10TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 857-254-4445
MAIL ADDRESS:
STREET 1: 400 TECHNOLOGY SQUARE
STREET 2: 10TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-03-01
0
0001827087
Vigil Neuroscience, Inc.
VIGL
0001889253
Thackaberry Evan
VIGIL NEUROSCIENCE, INC.
1 BROADWAY, 7TH FLOOR, SUITE 07-300
CAMBRIDGE
MA
02142
0
1
0
0
SVP, Head of Early Development
Stock Option Grant (Right to Buy)
16.13
2022-03-01
4
A
0
45000
0.00
A
2032-03-01
Common Stock
45000
45000
D
The shares subject to this option shall vest and become exercisable in forty-eight (48) equal monthly installments, with the first installment vesting on April 1, 2022.
/s/ Jennifer Ziolkowski, Attorney-in-Fact
2022-03-03